title: Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
authors.affiliation: Division of Nephrology, University of Maryland Hospital, Baltimore 21201.
authors.forename: S M
authors.initials: SM
authors.lastname: Zemel
authors.forename: S Y
authors.initials: SY
authors.lastname: Shen
authors.forename: M R
authors.initials: MR
authors.lastname: Weir
authors.forename: F J
authors.initials: FJ
authors.lastname: Dagher
authors.forename: F R
authors.initials: FR
authors.lastname: Bentley
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D001379:Azathioprine / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis*; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D000888:Antibodies, Anti-Idiotypic; D015415:Biomarkers; D003524:Cyclosporins; D006680:HLA Antigens; D001379:Azathioprine; D011241:Prednisone